By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


RXi Pharmaceuticals 

1500 West Park Drive
Suite 210
Westborough  Massachusetts  01581  U.S.A.
Phone: 508-767-3861 Fax: 508-767-3862


Company News
RXi Pharma (RXII) And Thera Neuropharma Enter Into An Exclusive License Agreement For RXi's Self-Delivering RNAi (sd-rxRNA) Platform Targeting SOD1 To Develop Therapeutics For Neurodegenerative Diseases, Such As ALS (Lou Gehrig's Disease) 5/3/2016 6:59:47 AM
RXi Pharma (RXII) Secures European Patent For Novel RNAi Platform 5/2/2016 6:10:27 AM
RXi Pharma (RXII) Announces Advancement Of Its Ophthalmology Franchise With Successful Topical Delivery Of sd-rxRNA To The Cornea In An In Vivo Corneal Wound Model 4/28/2016 7:36:55 AM
RXi Pharma (RXII) To Webcast First Quarter 2016 Financial Results On Thursday, May 12, 2016 4/27/2016 6:54:14 AM
RXi Pharma (RXII) Announces 'Biotech Spotlight' Presentation At The BioNetwork Partnering Summit 4/26/2016 9:53:20 AM
RXi Pharma (RXII) To Present At 18th Annual TIDES: Oligonucleotide And Peptides Therapeutics Conference 4/25/2016 8:26:10 AM
RXi Pharma (RXII) Fortifies Its Novel RNAi Patent Portfolio With Notice Of Allowance For Lead Clinical Candidate RXI-109 4/19/2016 6:31:02 AM
RXi Pharma (RXII) To Present At The Association for Research in Vision & Ophthalmology 2016 Annual Meeting 4/18/2016 9:58:51 AM
RXi Pharma (RXII) Announces Reverse Stock Split 4/18/2016 8:21:49 AM
RXi Pharma (RXII) Reports Fourth Quarter And Year End 2015 Financial Results And Recent Corporate Highlights 3/31/2016 8:52:23 AM